2-Thiophenesulfonyl Chloride CAS 16629-19-9 - China Factory, Suppliers, Manufacturers

2-Thiophenesulfonyl Chloride CAS 16629-19-9, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

D-(+)-Galactosamine Hydrochloride CAS 1772-03-8 Purity >99.0% (HPLC)

D-Mannosamine Hydrochloride CAS 5505-63-5 Assay >99.0% (HPLC)

D-(+)-Glucosamine Hydrochloride CAS 66-84-2 Assay 98.0%~102.0% Factory

Palonosetron Hydrochloride CAS 135729-62-3 Purity >99.0% (HPLC) (T) API Factory

3-Chloropropionyl Chloride CAS 625-36-5 Purity >98.5% (GC) Factory

Nickel(II) Chloride Hexahydrate CAS 7791-20-0 Ni ≥22.0% Factory

Top Selling Products

Related Blog
Reviews

Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...

2022.11.12 19:56:46
2022.10.11 15:02:45
2022.09.27 23:47:25
2022.08.21 17:44:11
2022.03.14 21:55:30
2022.02.18 20:59:02

2-Thiophenesulfonyl Chloride CAS 16629-19-9 - China Factory, Suppliers, Manufacturers

Related Products

2-Thiophenesulfonyl Chloride CAS 16629-19-9 Purity >98.0% (GC) Factory High Quality

D-(+)-Galactosamine Hydrochloride CAS 1772-03-8 Purity >99.0% (HPLC)

D-Mannosamine Hydrochloride CAS 5505-63-5 Assay >99.0% (HPLC)

D-(+)-Glucosamine Hydrochloride CAS 66-84-2 Assay 98.0%~102.0% Factory

Palonosetron Hydrochloride CAS 135729-62-3 Purity >99.0% (HPLC) (T) API Factory

3-Chloropropionyl Chloride CAS 625-36-5 Purity >98.5% (GC) Factory

Nickel(II) Chloride Hexahydrate CAS 7791-20-0 Ni ≥22.0% Factory

Top Selling Products

5-Fluoro-2-Methoxybenzoic Acid CAS 394-04-7 High Quality

Adenine CAS 73-24-5 Assay 98.0%~102.0% (Titration) High Purity Factory

2-Pyrrolidone CAS 616-45-5 Purity >99.0% (GC)

Bromoacetaldehyde Ethylene Acetal CAS 4360-63-8 Purity >99.0% (GC) Factory High Quality

4-(1H-Imidazol-1-yl)aniline CAS 2221-00-3 Purity ≥95.0% (GC) Factory

Ethyl Isonicotinate CAS 1570-45-2 Purity >99.0% (GC)

1,4,7-Triazacyclononane CAS 4730-54-5 Purity >98.0% (GC) Factory Hot Sale

L-Cysteine CAS 52-90-4 (H-Cys-OH) Assay 98.5~101.0% (Titration) Factory High Quality

Ceftaroline Fosamil 7-Position Side Chain CAS 75028-24-9 Purity: ≥99.0% (HPLC)

L-Cystine CAS 56-89-3 (H-Cys-OH)2 Assay 98.5~101.0% (Titration) Factory High Quality

4-Methoxysalicylic Acid CAS 2237-36-7 Purity >99.0% (HPLC) Factory

Iodotrimethylsilane CAS 16029-98-4 Purity >99.0% (Argentmetric Titration) Factory

Method Of Analyzing Palladium Content In Palladium Catalysts

Xi presents award to top scientists

The “Summit on COVID-19 Diagnostics & Treatment”

New COVID treatments offer hope

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

2022.11.12 19:56:46

2022.10.11 15:02:45

2022.09.27 23:47:25

2022.08.21 17:44:11

2022.03.14 21:55:30

2022.02.18 20:59:02

related search